Sublingual Cockroach Safety in Adults With Cockroach Allergy & Perennial Allergic Rhinitis With or Without Asthma
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
Immunotherapy may help reduce symptoms of allergy and asthma. Problems concerning compliance
and adverse events with subcutaneous allergen immunotherapy have generated interest in
delivering immunotherapy sublingually (under the tongue). The purpose of this study is to
evaluate the safety of a cockroach extract given sublingually to people with perennial
(year-round) allergic rhinitis, with or without asthma.
Phase:
Phase 1
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)